Nathalie COSTEDOAT-CHALUMEAU, MD, PhD
Centre de référence maladies auto-immunes et systémiques rares, Internal medicine, Cochin hospital, APHP · Assistance Publique - Hôpitaux de Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nathalie COSTEDOAT-CHALUMEAU, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:45 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04702256 · Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMFAssistance Publique - Hôpitaux de Paris · recruiting · Lupus Nephritis, Systemic Lupus Erythematosus (SLE) · principal investigator
- N/ANCT02782039 · Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)Assistance Publique - Hôpitaux de Paris · completed · Anti-Phospholipids Syndrome (APS), Systemic Lupus Erythematosus (SLE) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.